As of 5 Jul 2026, Take Solutions share price is ₹23.97. The stock opened at ₹22.26, compared to its previous close of ₹22.83. During today's trading session, Take Solutions share price moved in the range of ₹22.26 to ₹23.97, with an average price of ₹23.12 for the day. Looking at its last 52-week, the stock has touched a low of ₹8.88 and a high of ₹50.14. On the performance front, Take Solutions share price has declined by 40.83% over the last six months and is up 131.15% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹0.00 | ₹3.60 | ₹189.07 | ₹655.19 |
| Other Income | ₹10.22 | ₹0.86 | ₹8.45 | ₹16.57 |
| Total Revenue | ₹10.22 | ₹4.46 | ₹197.52 | ₹671.76 |
| Total Expenses | ₹9.48 | ₹27.73 | ₹232.40 | ₹757.07 |
| Profit Before Tax | ₹0.74 | -₹62.37 | -₹45.27 | -₹85.31 |
| Tax | ₹0.00 | ₹4.01 | ₹1.68 | ₹3.62 |
| Profit After Tax | ₹0.74 | -₹66.38 | -₹46.95 | -₹88.92 |
| EPS - Basic | ₹2.56 | -₹8.18 | -₹6.86 | -₹53.50 |
| EPS - Diluted | ₹2.56 | -₹8.18 | -₹6.86 | -₹53.50 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹37.44 | -₹118.39 | -₹98.67 | -₹771.02 |
| Income before WC changes | -₹8.91 | ₹3.97 | ₹24.12 | ₹54.10 |
| Change in Assets | -₹9.14 | ₹14.32 | ₹24.61 | -₹95.00 |
| Change in Liabilities | ₹1.97 | -₹9.48 | -₹27.25 | ₹92.06 |
| Change in WC | -₹7.18 | ₹4.85 | -₹2.64 | -₹2.94 |
| Cash flow from Operations | -₹16.37 | ₹9.32 | ₹20.02 | ₹29.62 |
| Cash flow from Investing | ₹22.21 | -₹7.46 | -₹2.13 | -₹30.64 |
| Cash flow from Financing | -₹3.24 | -₹11.74 | -₹35.72 | -₹54.51 |
| Total Cash Flow | ₹2.60 | -₹9.88 | -₹17.83 | -₹55.53 |
| Cash (Start of the year) | ₹0.85 | ₹10.72 | ₹29.00 | ₹38.97 |
| Cash (End of the year) | ₹3.37 | ₹0.85 | ₹10.72 | ₹29.00 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹12.93 | ₹52.82 | ₹134.18 | ₹136.78 |
| Current Assets | ₹23.55 | ₹35.28 | ₹90.19 | ₹1,086.32 |
| Total Assets | ₹36.48 | ₹88.11 | ₹224.38 | ₹1,223.10 |
| Current Liabilities | ₹15.95 | ₹89.16 | ₹100.90 | ₹1,006.75 |
| Net Current Asset | ₹7.60 | -₹53.88 | -₹10.71 | ₹79.57 |
| Non-Current Liabilities | ₹0.00 | ₹7.82 | ₹14.88 | ₹35.72 |
| Equity Capital | ₹20.53 | -₹8.87 | ₹108.60 | ₹180.62 |
| Total Equity & Liabilities | ₹36.48 | ₹88.11 | ₹224.38 | ₹1,223.10 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹0.90 | ₹5.42 | ₹56.23 | ₹18.00 |
| Other Income | ₹12.98 | ₹0.87 | ₹9.07 | ₹17.27 |
| Total Revenue | ₹13.88 | ₹6.29 | ₹65.29 | ₹35.27 |
| Total Expenses | ₹3.75 | ₹28.93 | ₹55.15 | ₹32.89 |
| Profit Before Tax | ₹10.13 | -₹71.05 | ₹4.70 | -₹2.75 |
| Tax | ₹0.00 | ₹4.01 | ₹0.41 | ₹2.37 |
| Profit After Tax | ₹10.13 | -₹75.06 | ₹4.29 | -₹5.12 |
| EPS - Basic | -₹4.72 | -₹14.01 | ₹0.29 | -₹32.26 |
| EPS - Diluted | -₹4.72 | -₹14.01 | ₹0.29 | -₹32.26 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹69.74 | -₹203.24 | ₹4.70 | -₹474.45 |
| Income before WC changes | -₹2.02 | -₹1.58 | ₹3.25 | -₹6.81 |
| Change in Assets | -₹12.86 | ₹7.81 | ₹24.71 | ₹34.34 |
| Change in Liabilities | -₹4.91 | -₹10.06 | ₹3.37 | ₹5.23 |
| Change in WC | -₹17.77 | -₹2.26 | ₹28.08 | ₹39.57 |
| Cash flow from Operations | -₹19.51 | -₹4.48 | ₹26.89 | ₹32.58 |
| Cash flow from Investing | ₹22.21 | -₹1.02 | -₹22.37 | -₹40.19 |
| Cash flow from Financing | -₹0.04 | -₹0.23 | -₹0.84 | -₹1.11 |
| Total Cash Flow | ₹2.66 | -₹5.73 | ₹3.69 | -₹8.72 |
| Cash (Start of the year) | ₹0.50 | ₹6.22 | ₹2.54 | ₹11.26 |
| Cash (End of the year) | ₹3.16 | ₹0.50 | ₹6.22 | ₹2.54 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹9.21 | ₹112.37 | ₹259.55 | ₹207.07 |
| Current Assets | ₹22.45 | ₹6.81 | ₹59.15 | ₹104.70 |
| Total Assets | ₹31.66 | ₹119.18 | ₹318.70 | ₹311.77 |
| Current Liabilities | ₹5.90 | ₹23.48 | ₹15.36 | ₹10.96 |
| Net Current Asset | ₹16.56 | -₹16.67 | ₹43.79 | ₹93.75 |
| Non-Current Liabilities | ₹0.00 | ₹0.28 | ₹0.57 | ₹2.37 |
| Equity Capital | ₹25.77 | ₹95.42 | ₹302.78 | ₹298.44 |
| Total Equity & Liabilities | ₹31.66 | ₹119.18 | ₹318.70 | ₹311.77 |
Take Solutions Limited is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.
Take Solutions share price is ₹23.97 as on 03 Jul, 2026, 15:29 IST.
In the last 1 year, Take Solutions delivered a return of 131.15%. The Take Solutions share price hit a high of ₹50.14 and low of ₹8.88.
The Mutual Fund Shareholding in Take Solutions was 0.00% at the end of Mar 2026.
The 52-week high and low of Take Solutions share is ₹50.14 and ₹8.88 as of 03 Jul, 2026.
The market capitalisation of Take Solutions is ₹341.43 Crores as on 03 Jul, 2026.
The stock symbol of Take Solutions is TAKE on the NSE, 532890 on the BSE, and the ISIN is INE142I01023.
Take Solutions shares closed yesterday at ₹22.83 on NSE & ₹23.08 on BSE
To buy Take Solutions shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of Take Solutions or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Take Solutions shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of Take Solutions is 31.62 and 11.01 respectively, as on 03 Jul, 2026, 15:29 IST.